Several studies have found that increased severity of liver chemistry abnormalities (such as ALT-AST elevation、AST/ALT ratio >1 (Medetalibeyoglu et al., 2020)and high levels of aspartate aminotransferase [AST] and direct bilirubin [D-Bil](Ding et al., 2021)) on hospital admission predict early in-hospital mortality in COVID-19 patients (Satapathy et al., 2021). This evidence concerns the gene GPT and COVID-19.